Cathie Wood's position in 10x Genomics is currently worth $227 Million. That's 1.56% of their equity portfolio (21st largest holding). The investor owns 4.35% of the outstanding 10x Genomics stock. The first 10x Genomics trade was made in Q2 2020. Since then Cathie Wood bought shares six more times and sold shares on five occasions. The investor's estimated purchase price is $552 Million, resulting in a loss of 59%.